Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Market Closed - Bombay S.E.
Other stock markets
 06:13:41 2024-05-28 am EDT 		5-day change 1st Jan Change
5,956 INR +1.21% Intraday chart for Dr. Reddy's Laboratories Limited +2.42% +2.72%
May. 28 Asian Equities Traded in the US as American Depositary Receipts Open Week Slightly Lower in Tuesday Trading MT
May. 28 Dr. Reddy's Laboratories Limited Announces Appointment of Milan Kalawadia as Chief Executive Officer, North America CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Dr. Reddy's Laboratories LLC, Russia Enters into Distribution Agreement with Novartis Pharma LLC
CI
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Lower
MT
Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading
MT
Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab
MT
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher
MT
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
MT
Asian Equities Traded in the US as American Depositary Receipts Begin Week Higher
MT
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
RE
Indian Equities Settle Flat on Wednesday, Dragged by Banks, FMCG Stocks
MT
Dr. Reddy's Consolidated Net Profit Jumps in Fiscal Q4; Shares Slide 3%
MT
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT
Dr. Reddy's Laboratories Fiscal Q4 Earnings, Revenue Gain
MT
India's Dr Reddy's beats Q4 profit estimates
RE
Dr. Reddy's Laboratories Limited Recommends Final Dividend for the Financial Year 2023-2024
CI
Dr. Reddy's Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher
MT
Dr. Reddy's Laboratories Launches Generic Doxycycline Capsules in US
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. News Dr. Reddy's Laboratories Limited
  5. Highlights